Shorted

Catalyst Metals (CYL) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Positive
1d ago

Catalyst Metals (ASX:CYL) Faces a Rough ASX Open as Oil Surges

Highlights Australian shares are set for a weaker start after a softer overnight lead from Wall Street. Oil has surged amid escalating US-Iran tensions, placing energy stocks in focus. Gold miners and agriculture stocks are also in focus as commodity markets deliver contrasting signals. The Australian share market is heading into Wednesday with several competing forces shaping the opening tone. After a subdued session for the [ASX 200], attention is turning to overnight movements across ...

Continue reading
Kalkine
Neutral
19 Aug

a2 Milk Company (ASX:AM) Catalyst Watch: What Could Move Shares Next on 19 August

Highlights The 19 August reporting calendar includes ARB Corporation, Bega Cheese, Breville Group, BWP Trust and Deterra Royalties among companies scheduled to report. a2 Milk Company (ASX:AM) is the primary company lens, while Wesfarmers (ASX:WES), Bega Cheese (ASX:BGA), Breville Group (ASX:BRG) provide category context. The article focuses on household demand, brand pricing and international growth without using directional investment recommendations. The central question for consumer stock...

Continue reading
Kalkine
Neutral
17 July

Catalyst Metals Limited Issues 357,100 Shares After Exercising Options Expiring August 2026

Catalyst Metals Limited (ASX: CYL) has applied for quotation of 357,100 fully paid ordinary shares on the ASX following the exercise of options set to expire on 11 August 2026. These shares were issued on 16 July 2026 at an exercise price of AUD 1.98 each. Post-issuance, the company’s total quoted ordinary shares amount to 261,302,108, alongside outstanding unquoted options and performance rights. Key Highlights Catalyst Metals Limited (CYL), an ASX-listed exploration and development firm, ...

Continue reading
Kalkine
Neutral
15 July

Is Catalyst Metals (ASX:CYL) Undervalued After Its Strongest Gold Production In More Than A Decade?

Highlights Catalyst Metals has reported its strongest annual gold production in more than a decade, supported by continued operational progress at the Plutonic Gold Belt. The company's improved production profile has renewed attention on its valuation despite recent share price volatility. Investors are monitoring whether operational momentum can support longer-term earnings growth and strengthen the company's investment outlook. Catalyst Metals (ASX:CYL) has returned to the spotlight after rep...

Continue reading
Kalkine
Positive
6 July

Is Catalyst Metals (ASX:CYL) Still Undervalued After Record Gold Production?

Highlights Catalyst Metals reports record gold production while maintaining a debt-free balance sheet. Ongoing project development continues strengthening the company's long-term production profile. Strong operational performance has renewed attention across Australia's gold mining sector. Catalyst Metals Ltd (ASX:CYL) has returned to the spotlight after reporting record quarterly and annual gold production from its Plutonic Gold Belt operations in Western Aus...

Continue reading
Kalkine
Positive
4 July

Catalyst Metals (ASX:CYL) Surges After Record Gold Output—Is There More to the Growth Story?

Highlights Catalyst Metals delivered record annual gold production while strengthening its financial position. A fully funded pipeline of new mining projects continues supporting long-term operational expansion. Production growth, reserve development and disciplined project execution remain central to the company's strategy. Catalyst Metals Ltd (ASX: CYL) has returned to the spotlight after reporting record annual gold production alongside continued progress a...

Continue reading
Kalkine
Neutral
23 June

Catalyst Metals (ASX:CYL): What’s Fueling Fresh Excitement Around This ASX 200 Gold Stock?

Highlights Catalyst Metals has reported a significant expansion of resources at its Trident gold project in Western Australia. The updated estimate strengthens the project's role within the company's broader production strategy. Continued exploration success across the Plutonic Gold Belt is supporting market interest in the miner. Catalyst Metals has reported strong resource growth at its Trident project, reinforcing the strategic importance of the Plutonic Gold Belt and supporting future dev...

Continue reading
Kalkine
Neutral
18 June

Penny Stock Volume Spike: Is The Next Catalyst Near?

Highlights Penny stocks are drawing attention as volume, catalysts and liquidity return to focus. Healthcare, technology and critical minerals names are shaping the smaller-company watchlist. Markets are applying a stricter filter around funding runway, execution and announcement quality. Penny stocks are drawing fresh attention as stronger volume, catalyst depth, healthcare innovation, technology sparks and critical minerals themes reshape the smaller-company ASX conversation. Australi...

Continue reading
Kalkine
Neutral
17 June

Catalyst Discipline Radar: Why Small Caps Are Drawing Fresh Attention

Highlights Catalyst Discipline Radar is emerging as a key theme as investors focus on company-specific developments rather than broad market sentiment. Announcements, contract wins and funding milestones are becoming important drivers for selected small-cap companies. Duratec, Northern Minerals, Weebit Nano and Bellevue Gold highlight how execution is increasingly shaping market attention. Company-specific catalysts are becoming increasingly important for ASX small-cap stocks as investors foc...

Continue reading
Kalkine
Neutral
29 May

Healthcare Stocks Enter a Catalyst-Rich Phase as Sector Eyes Fresh Momentum

Highlights Healthcare sector enters a news-driven period. Clinical and regulatory updates remain in focus. Innovation pipelines continue attracting attention. Australian healthcare and life sciences companies are approaching a catalyst-rich period marked by regulatory milestones, clinical study updates, commercial expansion initiatives, and technology advancements. Several healthcare businesses are drawing market attention as new developments shape the sector outlook across diagnostics,...

Continue reading